ARGX Stock Analysis: Buy, Sell, or Hold?
ARGX - argenx SE American Depositary Shares
$840.50
-7.22 (-0.85%)
▼
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
25d
Get Alerted When ARGX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ARGX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: ARGX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$1312.02
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$814.66
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ARGX is currently trading at $840.50, which is considered slightly high relative to its 30-day fair value range of $804.14 to $846.10. The stock's valuation (Forward PE: 31.5) is in line with its historical norms (31.8). Remarkably, the market is currently pricing in an annual earnings decline of 0.3% over the next few years. This pessimistic expectation contrasts with the company's recent 272.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, ARGX is in a uptrend. Immediate support is located at $781.07, while resistance sits at $881.89.
Market Sentiment: ARGX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (1th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $1047.51 (+23.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ARGX is in a uptrend. Immediate support is located at $781.07, while resistance sits at $881.89.
Market Sentiment: ARGX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (1th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $1047.51 (+23.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$804.14 -
$846.10
Company Quality Score
58/100
(HOLD)
Options IV Signal
1th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
80.8%
All Signals
- BULLISH: Options cheap (IV 1th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.6% below Wall St target ($1047.51)
Fair Price Analysis
30-Day Fair Range
$804.14 -
$846.10
Current vs Fair Value
SLIGHTLY HIGH
Expected Move (7 Days)
±$42.54
(5.1%)
Support & Resistance Levels
Support Level
$781.07
Resistance Level
$881.89
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
31.46
Wall Street Target
$1047.51
(+23.6%)
Revenue Growth (YoY)
95.5%
Earnings Growth (YoY)
272.7%
Profit Margin
41.6%
Valuation Discount vs History
-0.3% cheaper
PE vs Historical
31.5 vs 31.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.3%
(market-implied from PE analysis)
1-Year Target
$845.18
(0%)
2-Year Target
$842.64
(-1%)
3-Year Target
$840.11
(-1%)
3-Yr Target (if PE normalizes)
(PE: 31→32)
$849.31
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 31.5, Growth: 79.7%)
$2861.05
(+238%)
Base:
(SPY PE: 22.3, Growth: 79.7%)
$2028.31
(+139%)
Bear:
(PE: 19.0, Growth: 79.7%)
$1724.06
(+103%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (36x PE), but valuation improves significantly next year (31x PE) as earnings recover.
Trailing PE: 36.25 | Current EPS (TTM): $23.36
Bull Case
$1074.57
(+28%)
Analyst growth 15.4%, PE expands to 39.9
Base Case
$976.88
(+16%)
Market implied 15.4%, PE stable at 36.3
Bear Case
$575.79
(-32%)
Severe decline -20.0%, PE contracts to 30.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 31.5 to 31.8
Stabilization Target:
$857.00
(+1.1%)
PE Expansion Potential:
+1.1%
Last updated: January 30, 2026 7:48 PM ET
Data refreshes hourly during market hours. Next update: 8:48 PM
Data refreshes hourly during market hours. Next update: 8:48 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARGX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$90 | 59 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 56 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$35 | 51 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$65 | 60 HOLD |
Advanced ARGX Option Strategies
Professional options setups generated by AI based on today's ARGX price and gamma walls.
